Does ALEMTUZUMAB Cause Off label use? 1,259 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,259 reports of Off label use have been filed in association with ALEMTUZUMAB (Campath). This represents 8.9% of all adverse event reports for ALEMTUZUMAB.
1,259
Reports of Off label use with ALEMTUZUMAB
8.9%
of all ALEMTUZUMAB reports
275
Deaths
274
Hospitalizations
How Dangerous Is Off label use From ALEMTUZUMAB?
Of the 1,259 reports, 275 (21.8%) resulted in death, 274 (21.8%) required hospitalization, and 122 (9.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 1,259 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
Urinary tract infection (746)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ALEMTUZUMAB Alternatives Have Lower Off label use Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET